Bill > SB1

This bill establishes a comprehensive regulatory framework for consumable hemp products in Alabama, focusing on their sale, production, and oversight. Starting January 1, 2026, the bill mandates that nonpsychoactive hemp products can only be sold in licensed pharmacies that obtain annual certification from the Alabama State Board of Pharmacy. These products must contain only nonpsychoactive cannabinoids derived from hemp cultivated within the state and must undergo rigorous testing by the Department of Agriculture and Industries. The testing protocols include checks for cannabinoid content, potency, heavy metals, chemical contamination, microbials, and other potential contaminants. Each product must receive a certificate of analysis before being sold, and the department will maintain a seed-to-sale tracking system to monitor the entire production process. The bill also adds psychoactive derivatives of hemp to Schedule I controlled substances, effectively prohibiting their sale. Testing costs will be borne by hemp cultivators and processors, and pharmacies must maintain documentation of each product's certificate of analysis. The legislation aims to ensure product safety, consistency, and controlled distribution of hemp-derived consumable products in Alabama.

Health and Social Services

https://alison.legislature.state.al.us/bill-search